PhotoCure ASA (FRA:PHS) Other Gross PPE: €12.22 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PHS PhotoCure ASA FRA:PHS
80 GF Score
Price €4.80
GF Value €7.00
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is PhotoCure ASA Other Gross PPE?

PhotoCure ASA FRA:PHS +1.91% 80 Other Gross PPE is €12.22 Mil as of Jun. 2026. GuruFocus rates FRA:PHS with a GF Score™ of 80/100 and a GF Value™ of €7.00 (Significantly Undervalued). The stock has 1 warning sign investors should review.

PhotoCure ASA's Other Gross PPE for the quarter that ended in Jun. 2026 was €12.22 Mil.

PhotoCure ASA's quarterly Other Gross PPE increased from Dec. 2025 (€0.00 Mil) to Mar. 2026 (€1.22 Mil) and increased from Mar. 2026 (€1.22 Mil) to Jun. 2026 (€12.22 Mil).

PhotoCure ASA's annual Other Gross PPE declined from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€-0.00 Mil) but then increased from Dec. 2024 (€-0.00 Mil) to Dec. 2025 (€0.00 Mil).

PhotoCure ASA Other Gross PPE Historical Data

* Premium members only.

The historical data trend for PhotoCure ASA's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhotoCure ASA Other Gross PPE Chart

PhotoCure ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.00 0.00 -0.00 0.00

PhotoCure ASA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.40 1.24 0.00 1.22 12.22
FRA:PHS
80GF Score
PhotoCure ASA FRA:PHS
Other Gross PPE is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhotoCure ASA Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Frequently Asked Questions Learn more about Other Gross PPE →
What does a Other Gross PPE of €12.22 Mil mean?
PhotoCure ASA (FRA:PHS) has a Other Gross PPE of €12.22 Mil as of Jun. 2026. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on PhotoCure ASA and its competitors.
Is PhotoCure ASA's Other Gross PPE too high?
PhotoCure ASA's current Other Gross PPE is €12.22 Mil. Overall, PhotoCure ASA has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PhotoCure ASA's Other Gross PPE compare to ZTS and UTHR?
PhotoCure ASA's Other Gross PPE of €12.22 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Gross PPE for a Drug Manufacturers company?
A good Other Gross PPE depends on the Drug Manufacturers industry context. However, Other Gross PPE should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Gross PPE mean?
A high Other Gross PPE can signal that a stock is expensive relative to its fundamentals. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on PhotoCure ASA and its competitors. PhotoCure ASA's current Other Gross PPE is €12.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhotoCure ASA stock overvalued right now?
Based on GuruFocus' analysis, PhotoCure ASA (FRA:PHS) is currently considered Significantly Undervalued. The stock's GF Value™ is €7.00, compared to a current price of €4.80 — trading 31.5% below its estimated fair value. The current Other Gross PPE is €12.22 Mil. PhotoCure ASA's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Gross PPE calculated?
Other Gross PPE is calculated from a company's financial statements. For PhotoCure ASA (FRA:PHS), the current Other Gross PPE is €12.22 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhotoCure ASA (FRA:PHS) Overvalued in 2026?

Based on GuruFocus' analysis, PhotoCure ASA stock appears to be undervalued. The current stock price of €4.80 is trading 31.5% below its estimated GF Value™ of €7.00. GuruFocus considers PhotoCure ASA to be Significantly Undervalued.

Key valuation signals for FRA:PHS:

  • Other Gross PPE: €12.22 Mil
  • GF Value™: €7.00 vs. price of €4.80 (31.5% below fair value)
  • GF Score™: 80/100 with 1 warning sign

No single metric tells the full story. See the FRA:PHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PhotoCure ASA Business Description

Address Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.
80GF Score

Get the complete analysis for FRA:PHS

Other Gross PPE is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.80
Price
€7.00
GF Value